查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
白色生物技術市場 - 全球及區域分析：按應用、產品和國家 - 分析與預測（2025 年至 2034 年）
市場調查報告書
商品編碼
1757393

白色生物技術市場 - 全球及區域分析：按應用、產品和國家 - 分析與預測（2025 年至 2034 年）

White Biotechnology Market - A Global and Regional Analysis: Focus on Application, Product, and Country Analysis - Analysis and Forecast, 2025-2034
出版日期: | 出版商: BIS Research | 英文 120 Pages | 商品交期: 1-5個工作天內

價格

白色生物技術，也稱為工業生物技術，利用活細胞、酵素和發酵過程生產生物基化學品、材料和能源載體。

主要應用領域包括生質燃料（例如先進生物柴油和生質乙醇）、生物化學（有機酸、溶劑）、工業酶（用於清潔劑、紡織品和食品加工）、生物材料（生物聚合物、生質塑膠）以及生物修復和可再生原料增值等新興領域。合成生物學、代謝工程和蛋白質工程的技術進步使得更有效率的菌株開發、更高的產量和更低的製程成本成為可能。同時，用於生物製程最佳化的機器學習、高通量篩檢和可擴展的連續流發酵等數位工具正在加快新生物產品的上市時間。生物學數位化的融合正在推動白色生物技術市場從小眾專業應用向大規模工業用途的轉變。

白色生物技術市場生命週期階段

主要市場統計數據
預測期 2025-2034
2025年評估 3375.6億美元
2034年的預測 6729.2億美元
複合年成長率 7.97%

白色生物技術市場正處於成長階段，其特點是研發投入強勁、技術商業化快速推進，以及老牌化工企業和敏捷的生物技術新興企業群體的不斷壯大。創新分散在各個細分領域，從諾維信和杜邦等酵素製造商到生物基材料領域的先驅企業，市場集中度仍然較低，為新進業者留下了充足的發展空間。隨著生產流程效率的提升以及生物基產品法律規範的日趨成熟，未來十年，該行業很可能走向整合和成熟，重大戰略聯盟和併購將塑造競爭格​​局。

白色生物技術市場細分

細分一：按應用

  • 生質能源
  • 食品/飼料添加劑
  • 醫藥原料
  • 個人護理和家居產品
  • 其他

生質能源是全球白色生物技術市場突出的應用領域之一。

細分2：依產品類型

  • 生物化學
  • 生質燃料
  • 生物材料
  • 生物製品

根據產品類型，全球白色生物技術市場估計由生物化學領域主導。

細分3：按地區

  • 北美—美國、加拿大、墨西哥
  • 歐洲——德國、法國、義大利、西班牙、英國等。
  • 亞太地區－中國、日本、韓國、印度及世界其他地區
  • 其他——南美洲、中東和非洲

在白色生物技術市場中，由於對可再生資源的需求不斷成長以及政府的舉措，北美預計將在生產方面獲得推動力。

需求——促進因素與限制因素

以下是推動全球白色生物技術市場需求的因素：

  • 對可再生資源的需求不斷增加

由於以下挑戰，全球白色生物技術市場預計還將面臨一些限制：

  • 初期投資成本高

白色生物技術市場：主要企業與競爭格局

白色生物技術市場的競爭格局呈現多元化特徵，由老牌化學和生命科學公司以及一波專注於生物技術的創新企業主導。諾維信公​​司、杜邦公司、BASF公司和贏創工業股份公司等主要企業正利用其強大的研發能力和全球生產網路，大規模供應工業酵素、生物基聚合物和特種生物化學品。同時，Amyris公司、Genomatica公司、Codexis公司和Ginkgo Bioworks等敏捷的純生物技術公司正憑藉先進的代謝工程、專有菌株開發平台和數位化生物製程最佳化工具，在加快產品上市速度和降低單位成本方面脫穎而出。阿徹丹尼爾斯米德蘭公司、嘉吉公司、科比昂公司和龍沙集團等中型市場公司正在原料整合和循環經濟解決方案方面展開競爭，而充滿活力的併購環境以及將化工巨頭與生物技術企業聯繫起來的戰略夥伴關係繼續重塑市場佔有率、推動整合並促進下一代技術轉移。

本報告研究了全球白色生物技術市場，並概述了市場、應用、產品和國家趨勢以及參與市場的公司概況。

目錄

執行摘要

第1章市場：產業展望

  • 趨勢：現況與未來影響評估
  • 相關利益者分析
    • 使用案例
    • 最終用戶和購買標準
  • 市場動態概覽
    • 市場促進因素
    • 市場限制
    • 市場機會
  • 投資狀況及研發趨勢
  • 未來展望與市場藍圖

第2章 白色生物技術市場（依應用）

  • 應用程式細分
  • 使用摘要
  • 白色生物技術市場（按應用）
    • 生質能源
    • 食品/飼料添加劑
    • 醫藥原料
    • 個人保健產品和家居產品
    • 其他

第3章 白色生物技術市場（依產品）

  • 產品細分
  • 產品摘要
  • 白色生物技術市場（按產品類型）
    • 生物化學
    • 生質燃料
    • 生物材料
    • 生物製品

第4章 白色生物技術市場（按地區）

  • 白色生物技術市場（按地區）
  • 北美洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 主要企業
    • 目的
    • 產品
    • 北美（按國家/地區）
  • 歐洲
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 主要企業
    • 目的
    • 產品
    • 歐洲（按國家/地區）
  • 亞太地區
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 主要企業
    • 目的
    • 產品
    • 亞太地區（按國家/地區）
  • 其他地區
    • 區域概況
    • 市場成長動力
    • 成長抑制因素
    • 主要企業
    • 目的
    • 產品
    • 其他地區（按地區）

第5章 市場競爭基準化分析與公司概況

  • 未來展望
  • 地理評估
  • 公司簡介
    • Medtronic
    • Novozymes
    • BASF SE
    • DuPont
    • Cargill, Inc.
    • Royal DSM NV
    • Archer Daniles Midland Company
    • BioAmber Inc.
    • Lesaffre
    • Corbion NV
    • Evonik Industries AG
    • Genomatica, Inc
    • Ginkgo Bioworks
    • Amyris Inc.
    • TerraVia Holdings, Inc
  • 其他主要企業

第6章調查方法

Product Code: MC02960SA

Global White Biotechnology Market: Industry Overview

White biotechnology also known as industrial biotechnology leverages living cells, enzymes and fermentation processes to produce bio-based chemicals, materials and energy carriers. Core application areas include biofuels (e.g., advanced biodiesel and bioethanol), biochemicals (organic acids, solvents), industrial enzymes (for detergents, textiles, food processing), biomaterials (biopolymers, bioplastics) and emerging fields such as bioremediation and renewable feedstock valorization. Technological advances in synthetic biology, metabolic engineering and protein engineering are enabling more efficient strain development, higher yields and reduced process costs. Concurrently, digital tools-machine learning for bioprocess optimization, high-throughput screening and scalable continuous-flow fermentation-are accelerating time-to-market for new bioproducts. This convergence of biology and digitalization is driving white biotechnology market's transformation from niche specialty applications toward large-scale industrial adoption.

White Biotechnology Market Lifecycle Stage

KEY MARKET STATISTICS
Forecast Period2025 - 2034
2025 Evaluation$337.56 Billion
2034 Forecast$672.92 Billion
CAGR7.97%

The white biotechnology market is firmly in its growth phase, characterized by robust R&D investment, rapid technology commercialization and an expanding base of both established chemical-industry incumbents and agile biotech startups. Market concentration remains moderate, with innovation dispersed across diverse segments-from enzyme producers like Novozymes and DuPont to bio-based materials pioneers-indicating ample room for new entrants. As process efficiencies improve and regulatory frameworks for bio-based products mature, the industry is poised to transition toward consolidation and maturation over the next decade, with large strategic partnerships and mergers likely to shape the competitive landscape.

White Biotechnology Market Segmentation:

Segmentation 1: by Application

  • Bioenergy
  • Food and Feed Additives
  • Pharmaceutical Ingredients
  • Personal Care and Household Products
  • Others

Bioenergy is one of the prominent application segments in the global white biotechnology market.

Segmentation 2: by Product Type

  • Biochemical
  • Biofuel
  • Biomaterial
  • Bioproduct

The global white biotechnology market is estimated to be led by the biochemical segment in terms of product type.

Segmentation 3: by Region

  • North America - U.S., Canada, and Mexico
  • Europe - Germany, France, Italy, Spain, U.K., and Rest-of-Europe
  • Asia-Pacific - China, Japan, South Korea, India, and Rest-of-Asia-Pacific
  • Rest-of-the-World - South America and Middle East and Africa

In the white biotechnology market, North America is anticipated to gain traction in terms of production, with increasing demand towards renewable resources and govement initiatives.

Demand - Drivers and Limitations

The following are the demand drivers for the global white biotechnology market:

  • Increasing Demand Towards Renewable Resources

The global white biotechnology market is expected to face some limitations as well due to the following challenges:

  • High Initial Investment Costs

White Biotechnology Market Key Players and Competition Synopsis

The white biotechnology market sector is characterized by a diverse competitive landscape dominated by established chemical and life-sciences firms alongside a wave of specialized biotech innovators. Leading companies-such as Novozymes A/S, DuPont de Nemours, BASF SE, Evonik Industries AG-leverage extensive R&D capabilities and global production networks to supply industrial enzymes, bio-based polymers and specialty biochemicals at scale. At the same time, agile pure-play biotechnology companies-Amyris Inc., Genomatica Inc., Codexis Inc. and Ginkgo Bioworks-are differentiating themselves through advanced metabolic engineering, proprietary strain-development platforms and digital bioprocess optimization tools that accelerate time-to-market and reduce unit costs. Mid-tier players including Archer Daniels Midland, Cargill Incorporated, Corbion N.V. and Lonza Group Ltd. compete on feedstock integration and circular-economy solutions, while an active M&A environment and strategic partnerships-linking chemical giants with biotech startups-continue to reshape market share, drive consolidation and foster next-generation technology transfer.

Some prominent names established in the white biotechnology market are:

  • Medtronic
  • Novozymes
  • BASF SE
  • DuPont
  • Cargill, Inc.
  • Royal DSM N.V.
  • Archer Daniles Midland Company
  • BioAmber Inc.
  • Lesaffre
  • Corbion N.V.
  • Evonik Industries AG
  • Genomatica, Inc
  • Ginkgo Bioworks
  • Amyris Inc.
  • TerraVia Holdings, Inc

Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1. Markets: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
  • 1.2 Stakeholder Analysis
    • 1.2.1 Use Case
    • 1.2.2 End User and Buying Criteria
  • 1.3 Market Dynamics Overview
    • 1.3.1 Market Drivers
    • 1.3.2 Market Restraints
    • 1.3.3 Market Opportunities
  • 1.4 Investment Landscape and R&D Trends
  • 1.5 Future Outlook and Market Roadmap

2. White Biotechnology Market (by Application)

  • 2.1 Application Segmentation
  • 2.2 Application Summary
  • 2.3 White Biotechnology Market (by Application)
    • 2.3.1 Bioenergy
    • 2.3.2 Food and Feed Additives
    • 2.3.3 Pharmaceutical Ingredients
    • 2.3.4 Personal Care and Household Products
    • 2.3.5 Others

3. White Biotechnology Market (by Product)

  • 3.1 Product Segmentation
  • 3.2 Product Summary
  • 3.3 White Biotechnology Market (by Product Type)
    • 3.3.1 Biochemical
    • 3.3.2 Biofuel
    • 3.3.3 Biomaterial
    • 3.3.4 Bioproduct

4. White Biotechnology Market (by Region)

  • 4.1 White Biotechnology Market (by Region)
  • 4.2 North America
    • 4.2.1 Regional Overview
    • 4.2.2 Driving Factors for Market Growth
    • 4.2.3 Factors Challenging the Market
    • 4.2.4 Key Companies
    • 4.2.5 Application
    • 4.2.6 Product
    • 4.2.7 North America (by Country)
      • 4.2.7.1 U.S.
        • 4.2.7.1.1 Market by Application
        • 4.2.7.1.2 Market by Product
      • 4.2.7.2 Canada
        • 4.2.7.2.1 Market by Application
        • 4.2.7.2.2 Market by Product
  • 4.3 Europe
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Key Companies
    • 4.3.5 Application
    • 4.3.6 Product
    • 4.3.7 Europe (by Country)
      • 4.3.7.1 Germany
        • 4.3.7.1.1 Market by Application
        • 4.3.7.1.2 Market by Product
      • 4.3.7.2 France
        • 4.3.7.2.1 Market by Application
        • 4.3.7.2.2 Market by Product
      • 4.3.7.3 Italy
        • 4.3.7.3.1 Market by Application
        • 4.3.7.3.2 Market by Product
      • 4.3.7.4 Spain
        • 4.3.7.4.1 Market by Application
        • 4.3.7.4.2 Market by Product
      • 4.3.7.5 U.K.
        • 4.3.7.5.1 Market by Application
        • 4.3.7.5.2 Market by Product
      • 4.3.7.6 Rest-of-Europe
        • 4.3.7.6.1 Market by Application
        • 4.3.7.6.2 Market by Product
  • 4.4 Asia-Pacific
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Key Companies
    • 4.4.5 Application
    • 4.4.6 Product
    • 4.4.7 Asia-Pacific (by Country)
      • 4.4.7.1 China
        • 4.4.7.1.1 Market by Application
        • 4.4.7.1.2 Market by Product
      • 4.4.7.2 Japan
        • 4.4.7.2.1 Market by Application
        • 4.4.7.2.2 Market by Product
      • 4.4.7.3 India
        • 4.4.7.3.1 Market by Application
        • 4.4.7.3.2 Market by Product
      • 4.4.7.4 South Korea
        • 4.4.7.4.1 Market by Application
        • 4.4.7.4.2 Market by Product
      • 4.4.7.5 Rest-of-Asia-Pacific
        • 4.4.7.5.1 Market by Application
        • 4.4.7.5.2 Market by Product
  • 4.5 Rest-of-the-World
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 Key Companies
    • 4.5.5 Application
    • 4.5.6 Product
    • 4.5.7 Rest-of-the-World (by Region)
      • 4.5.7.1 South America
        • 4.5.7.1.1 Market by Application
        • 4.5.7.1.2 Market by Product
      • 4.5.7.2 Middle East and Africa
        • 4.5.7.2.1 Market by Application
        • 4.5.7.2.2 Market by Product

5. Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Next Frontiers
  • 5.2 Geographic Assessment
  • 5.3 Company Profiles
    • 5.3.1 Medtronic
      • 5.3.1.1 Overview
      • 5.3.1.2 Top Products/Product Portfolio
      • 5.3.1.3 Top Competitors
      • 5.3.1.4 Target Customers
      • 5.3.1.5 Key Personnel
      • 5.3.1.6 Analyst View
      • 5.3.1.7 Market Share
    • 5.3.2 Novozymes
      • 5.3.2.1 Overview
      • 5.3.2.2 Top Products/Product Portfolio
      • 5.3.2.3 Top Competitors
      • 5.3.2.4 Target Customers
      • 5.3.2.5 Key Personnel
      • 5.3.2.6 Analyst View
      • 5.3.2.7 Market Share
    • 5.3.3 BASF SE
      • 5.3.3.1 Overview
      • 5.3.3.2 Top Products/Product Portfolio
      • 5.3.3.3 Top Competitors
      • 5.3.3.4 Target Customers
      • 5.3.3.5 Key Personnel
      • 5.3.3.6 Analyst View
      • 5.3.3.7 Market Share
    • 5.3.4 DuPont
      • 5.3.4.1 Overview
      • 5.3.4.2 Top Products/Product Portfolio
      • 5.3.4.3 Top Competitors
      • 5.3.4.4 Target Customers
      • 5.3.4.5 Key Personnel
      • 5.3.4.6 Analyst View
      • 5.3.4.7 Market Share
    • 5.3.5 Cargill, Inc.
      • 5.3.5.1 Overview
      • 5.3.5.2 Top Products/Product Portfolio
      • 5.3.5.3 Top Competitors
      • 5.3.5.4 Target Customers
      • 5.3.5.5 Key Personnel
      • 5.3.5.6 Analyst View
      • 5.3.5.7 Market Share
    • 5.3.6 Royal DSM N.V.
      • 5.3.6.1 Overview
      • 5.3.6.2 Top Products/Product Portfolio
      • 5.3.6.3 Top Competitors
      • 5.3.6.4 Target Customers
      • 5.3.6.5 Key Personnel
      • 5.3.6.6 Analyst View
      • 5.3.6.7 Market Share
    • 5.3.7 Archer Daniles Midland Company
      • 5.3.7.1 Overview
      • 5.3.7.2 Top Products/Product Portfolio
      • 5.3.7.3 Top Competitors
      • 5.3.7.4 Target Customers
      • 5.3.7.5 Key Personnel
      • 5.3.7.6 Analyst View
      • 5.3.7.7 Market Share
    • 5.3.8 BioAmber Inc.
      • 5.3.8.1 Overview
      • 5.3.8.2 Top Products/Product Portfolio
      • 5.3.8.3 Top Competitors
      • 5.3.8.4 Target Customers
      • 5.3.8.5 Key Personnel
      • 5.3.8.6 Analyst View
      • 5.3.8.7 Market Share
    • 5.3.9 Lesaffre
      • 5.3.9.1 Overview
      • 5.3.9.2 Top Products/Product Portfolio
      • 5.3.9.3 Top Competitors
      • 5.3.9.4 Target Customers
      • 5.3.9.5 Key Personnel
      • 5.3.9.6 Analyst View
      • 5.3.9.7 Market Share
    • 5.3.10 Corbion N.V.
      • 5.3.10.1 Overview
      • 5.3.10.2 Top Products/Product Portfolio
      • 5.3.10.3 Top Competitors
      • 5.3.10.4 Target Customers
      • 5.3.10.5 Key Personnel
      • 5.3.10.6 Analyst View
      • 5.3.10.7 Market Share
    • 5.3.11 Evonik Industries AG
      • 5.3.11.1 Overview
      • 5.3.11.2 Top Products/Product Portfolio
      • 5.3.11.3 Top Competitors
      • 5.3.11.4 Target Customers
      • 5.3.11.5 Key Personnel
      • 5.3.11.6 Analyst View
      • 5.3.11.7 Market Share
    • 5.3.12 Genomatica, Inc
      • 5.3.12.1 Overview
      • 5.3.12.2 Top Products/Product Portfolio
      • 5.3.12.3 Top Competitors
      • 5.3.12.4 Target Customers
      • 5.3.12.5 Key Personnel
      • 5.3.12.6 Analyst View
      • 5.3.12.7 Market Share
    • 5.3.13 Ginkgo Bioworks
      • 5.3.13.1 Overview
      • 5.3.13.2 Top Products/Product Portfolio
      • 5.3.13.3 Top Competitors
      • 5.3.13.4 Target Customers
      • 5.3.13.5 Key Personnel
      • 5.3.13.6 Analyst View
      • 5.3.13.7 Market Share
    • 5.3.14 Amyris Inc.
      • 5.3.14.1 Overview
      • 5.3.14.2 Top Products/Product Portfolio
      • 5.3.14.3 Top Competitors
      • 5.3.14.4 Target Customers
      • 5.3.14.5 Key Personnel
      • 5.3.14.6 Analyst View
      • 5.3.14.7 Market Share
    • 5.3.15 TerraVia Holdings, Inc
      • 5.3.15.1 Overview
      • 5.3.15.2 Top Products/Product Portfolio
      • 5.3.15.3 Top Competitors
      • 5.3.15.4 Target Customers
      • 5.3.15.5 Key Personnel
      • 5.3.15.6 Analyst View
      • 5.3.15.7 Market Share
  • 5.4 Other Key Companies

6. Research Methodology

List of Figures

  • Figure 1: White Biotechnology Market (by Scenario), $Billion, 2025, 2028, and 2034
  • Figure 2: White Biotechnology Market (by Region), $Billion, 2024, 2027, and 2034
  • Figure 3: White Biotechnology Market (by Application), $Billion, 2024, 2027, and 2034
  • Figure 4: White Biotechnology Market (by Product), $Billion, 2024, 2027, and 2034
  • Figure 5: Competitive Landscape Snapshot
  • Figure 6: Supply Chain Analysis
  • Figure 7: Value Chain Analysis
  • Figure 8: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 9: U.S. White Biotechnology Market, $Billion, 2024-2034
  • Figure 10: Canada White Biotechnology Market, $Billion, 2024-2034
  • Figure 11: Germany White Biotechnology Market, $Billion, 2024-2034
  • Figure 12: France White Biotechnology Market, $Billion, 2024-2034
  • Figure 13: Italy White Biotechnology Market, $Billion, 2024-2034
  • Figure 14: Spain White Biotechnology Market, $Billion, 2024-2034
  • Figure 15: U.K. White Biotechnology Market, $Billion, 2024-2034
  • Figure 16: Rest-of-Europe White Biotechnology Market, $Billion, 2024-2034
  • Figure 17: China White Biotechnology Market, $Billion, 2024-2034
  • Figure 18: Japan White Biotechnology Market, $Billion, 2024-2034
  • Figure 19: India White Biotechnology Market, $Billion, 2024-2034
  • Figure 20: South Korea White Biotechnology Market, $Billion, 2024-2034
  • Figure 21: Rest-of-Asia-Pacific White Biotechnology Market, $Billion, 2024-2034
  • Figure 22: South America White Biotechnology Market, $Billion, 2024-2034
  • Figure 23: Middle East and Africa White Biotechnology Market, $Billion, 2024-2034
  • Figure 24: Strategic Initiatives (by Company), 2021-2025
  • Figure 25: Share of Strategic Initiatives, 2021-2025
  • Figure 26: Data Triangulation
  • Figure 27: Top-Down and Bottom-Up Approach
  • Figure 28: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Region
  • Table 3: Trends Overview
  • Table 4: Application Summary (by Application)
  • Table 5: Product Summary (by Product)
  • Table 6: White Biotechnology Market (by Region), $Billion, 2024-2034
  • Table 7: North America White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 8: North America White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 9: U.S. White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 10: U.S. White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 11: Canada White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 12: Canada White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 13: Europe White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 14: Europe White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 15: Germany White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 16: Germany White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 17: France White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 18: France White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 19: Italy White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 20: Italy White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 21: Spain White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 22: Spain White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 23: U.K. White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 24: U.K. White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 25: Rest-of-Europe White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 26: Rest-of-Europe White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 27: Asia-Pacific White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 28: Asia-Pacific White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 29: China White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 30: China White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 31: Japan White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 32: Japan White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 33: India White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 34: India White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 35: South Korea White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 36: South Korea White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 37: Rest-of-Asia-Pacific White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 38: Rest-of-Asia-Pacific White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 39: Rest-of-the-World White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 40: Rest-of-the-World White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 41: South America White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 42: South America White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 43: Middle East and Africa White Biotechnology Market (by Application), $Billion, 2024-2034
  • Table 44: Middle East and Africa White Biotechnology Market (by Product), $Billion, 2024-2034
  • Table 45: Market Share